SGRY Valuation

Surgery Partners Inc

Add to Watchlist

Advanced Chart

22.940

-0.7(-2.961%)1D

Overview
Forecast
Valuation
Earnings

SGRY Relative Valuation

SGRY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SGRY is overvalued; if below, it's undervalued.

Historical Valuation

Surgery Partners Inc (SGRY) is now in the Fair zone, suggesting that its current forward PS ratio of 0.84 is considered Fairly compared with the five-year average of -333.79. The fair price of Surgery Partners Inc (SGRY) is between 22.02 to 39.99 according to relative valuation methord.

Relative Value

Fair Zone

22.02-39.99

Current Price：22.94

Fair

25.79

Trailing

Forward

14.40

EV/EBITDA

Surgery Partners Inc. (SGRY) has a current EV/EBITDA of 14.40. The 5-year average EV/EBITDA is 18.32. The thresholds are as follows: Strongly Undervalued below 11.54, Undervalued between 11.54 and 14.93, Fairly Valued between 21.70 and 14.93, Overvalued between 21.70 and 25.09, and Strongly Overvalued above 25.09. The current Forward EV/EBITDA of 14.40 falls within the Undervalued range.

18.73

EV/EBIT

Surgery Partners Inc. (SGRY) has a current EV/EBIT of 18.73. The 5-year average EV/EBIT is 20.00. The thresholds are as follows: Strongly Undervalued below 15.17, Undervalued between 15.17 and 17.58, Fairly Valued between 22.42 and 17.58, Overvalued between 22.42 and 24.83, and Strongly Overvalued above 24.83. The current Forward EV/EBIT of 18.73 falls within the Historic Trend Line -Fairly Valued range.

0.84

Surgery Partners Inc. (SGRY) has a current PS of 0.84. The 5-year average PS is 1.23. The thresholds are as follows: Strongly Undervalued below 0.41, Undervalued between 0.41 and 0.82, Fairly Valued between 1.64 and 0.82, Overvalued between 1.64 and 2.05, and Strongly Overvalued above 2.05. The current Forward PS of 0.84 falls within the Historic Trend Line -Fairly Valued range.

7.36

P/OCF

Surgery Partners Inc. (SGRY) has a current P/OCF of 7.36. The 5-year average P/OCF is -168.24. The thresholds are as follows: Strongly Undervalued below -1849.33, Undervalued between -1849.33 and -1008.79, Fairly Valued between 672.30 and -1008.79, Overvalued between 672.30 and 1512.84, and Strongly Overvalued above 1512.84. The current Forward P/OCF of 7.36 falls within the Historic Trend Line -Fairly Valued range.

9.42

P/FCF

Surgery Partners Inc. (SGRY) has a current P/FCF of 9.42. The 5-year average P/FCF is 3.70. The thresholds are as follows: Strongly Undervalued below -172.16, Undervalued between -172.16 and -84.23, Fairly Valued between 91.63 and -84.23, Overvalued between 91.63 and 179.57, and Strongly Overvalued above 179.57. The current Forward P/FCF of 9.42 falls within the Historic Trend Line -Fairly Valued range.

Surgery Partners Inc (SGRY) has a current Price-to-Book (P/B) ratio of 1.72. Compared to its 3-year average P/B ratio of 1.92 , the current P/B ratio is approximately -10.27% higher. Relative to its 5-year average P/B ratio of 4.12, the current P/B ratio is about -58.18% higher. Surgery Partners Inc (SGRY) has a Forward Free Cash Flow (FCF) yield of approximately 5.93%. Compared to its 3-year average FCF yield of 4.25%, the current FCF yield is approximately 39.60% lower. Relative to its 5-year average FCF yield of 5.15% , the current FCF yield is about 15.15% lower.

1.72

P/B

Median3y

1.92

Median5y

4.12

5.93

FCF Yield

Median3y

4.25

Median5y

5.15

Competitors Valuation Multiple

The average P/S ratio for SGRY's competitors is 0.65, providing a benchmark for relative valuation. Surgery Partners Inc Corp (SGRY) exhibits a P/S ratio of 0.84, which is 28.22% above the industry average. Given its robust revenue growth of 8.41%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Brookdale Senior Living Inc

National Healthcare Corp

Loss

24.70%

1.56B

Performance Decomposition

Market capitalization of SGRY decreased by 26.01% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 3.73 to 5.43.

The secondary factor is the Revenue Growth, contributed 8.41%to the performance.

Overall, the performance of SGRY in the past 1 year is driven by Margin Expansion. Which is more sustainable.

8.41%

762.10M → 826.20M

Revenue Growth

45.58%

3.73 → 5.43

Margin Expansion

-80.00%

-82.79 → -16.56

P/E Change

-26.01%